Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Washington University Center for Diabetes Translation Research Health Informatics in Diabetes Research Core Resource Report Resource Website |
Washington University Center for Diabetes Translation Research Health Informatics in Diabetes Research Core (RRID:SCR_015206) | access service resource, core facility, service resource, resource | Core facility whose services include consultation for management of complex datasets and literature resources, as well as promoting education of data analysis tools for researchers. | health informations, data management, data analysis, data science education, diabetes translational research |
is listed by: NIDDK Information Network (dkNET) is listed by: ABRF CoreMarketplace has parent organization: Washington University in St. Louis; Missouri; USA is organization facet of: Washington University Center for Diabetes Translation Research |
Diabetes | NIDDK P30DK092950 | Open | ABRF_5991 | https://coremarketplace.org/RRID:SCR_015206/?citation=1 | https://cdtr.wustl.edu/our-cores/health-informatics/ | SCR_015206 | 2026-07-27 09:34:51 | 0 | |||||
|
Washington University Center for Diabetes Translation Research Solutions to Diabetes in Black Americans Core Resource Report Resource Website |
Washington University Center for Diabetes Translation Research Solutions to Diabetes in Black Americans Core (RRID:SCR_015215) | access service resource, core facility, service resource, resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on June 15,2026. Core facility whose services include consultation about the challenges that Black Americans face regarding diet and food advertising, study design and implementation assistance, and positing relevant questions to the larger core for relevant research questions. | diabetes translation research, diabetes in black americans, community engagement, community outreach, food advertising |
is listed by: NIDDK Information Network (dkNET) has parent organization: Washington University in St. Louis; Missouri; USA has parent organization: Washington University Center for Diabetes Translation Research is organization facet of: Washington University Center for Diabetes Translation Research |
Diabetes | NIDDK P30DK092950 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015215 | 2026-07-27 09:34:51 | 0 | ||||||||
|
MMPC-Vanderbilt University School of Medicine Cardiovascular Pathophysiology Core Resource Report Resource Website |
MMPC-Vanderbilt University School of Medicine Cardiovascular Pathophysiology Core (RRID:SCR_015353) | access service resource, core facility, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 6th,2023. Core whose objective is to provide investigators at Vanderbilt and outside institutions a means to accurately assess cardiovascular phenotypes in mouse models of diabetes and metabolic disease. The CPC uses validated approaches and state-of-the-art instrumentation that allow for sensitive screening of phenotypic variations. | cardiovascular phenotype, cardiovascular mouse model, diabetes mouse model, metabolic mouse model |
is listed by: NIDDK Information Network (dkNET) has parent organization: National Mouse Metabolic Phenotyping Centers has parent organization: MMPC-Vanderbilt University School of Medicine is organization facet of: MMPC-Vanderbilt University School of Medicine |
Diabetes, metabolic disease | NIDDK U24 DK059637 | THIS RESOURCE IS NO LONGER IN SERVICE | SCR_015353 | 2026-07-27 09:35:04 | 0 | ||||||||
|
MMPC-University of California Davis Energy Balance Exercise and Behavior Core Resource Report Resource Website 1+ mentions |
MMPC-University of California Davis Energy Balance Exercise and Behavior Core (RRID:SCR_015364) | access service resource, core facility, service resource, resource | Core that provides investigators with services to accurately measure the major components of energy balance in their mouse models and tests that allow investigators to examine physiological factors that may influence food intake or energy expenditure. | energy balance, exercise and behavior, obesity |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of California at Davis; California; USA has parent organization: National Mouse Metabolic Phenotyping Centers has parent organization: MMPC-University of California Davis is organization facet of: MMPC-University of California Davis |
Obesity, Diabetes, metabolic disease | NIDDK DK092993 | Available to the research community | SCR_015364 | 2026-07-27 09:34:55 | 6 | ||||||||
|
Rare and Atypical Diabetes Network Resource Report Resource Website 1+ mentions |
Rare and Atypical Diabetes Network (RRID:SCR_024732) | RADIANT | database, topical portal, disease-related portal, portal, data or information resource | Portal dedicated to characterizing, discovering and defining rare and atypical forms of diabetes. Network of universities, hospitals and clinics across the United States dedicated to better understanding atypical diabetes. Team of academic institutions and scientists collaborates with physicians and healthcare groups to identify those with atypical diabetes and learn more about their health. | USA, universities network, hospitals and clinics network, characterizing atypical diabetes, discovering atypical diabetes, defining atypical diabetes, rare and atypical forms of diabetes, atypical diabetes, |
is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Central Repository |
rare and atypical forms of diabetes, Diabetes | NIDDK | Restricted | SCR_024732 | Rare and Atypical DIAbetes NeTwork | 2026-07-27 09:37:12 | 2 | ||||||
|
reMYND Resource Report Resource Website 1+ mentions |
reMYND (RRID:SCR_003824) | reMYND | commercial organization | Organization that drives the development of disease-modifying treatments against Alzheimer's, Parkinson's, Diabetes and other protein misfolding disorders through two independently managed business units: * Contract Research: The in-vivo Contract Research Organization (CRO) helps its clients to assess the pharmacokinetics and -dynamics of their experimental treatments against Alzheimer's disease. The main focus is on efficacy testing of candidate drugs in reMYND's proprietary Alzheimer mouse models expressing the clinical APP-London allele as single transgene or in combination with clinical alleles of human PS1 and TAU. * Drug Discovery: The Drug Discovery and Development Unit (DDD) focuses on disease-modifying treatments against protein-misfolding disorders, such as Alzheimer's disease (tau), Parkinson's disease (-synuclein), and Diabetes. In addition, reMYND grants licenses and markets commercial kits of RadarScreen, a technology for rapid and cost-effective identification of genotoxic liabilities in early stage drug discovery. reMYND has been substantially supported by grants from IWT and from The Michael J Fox Foundation. | protein misfolding | Alzheimer's disease, Parkinson's disease, Diabetes | IWT ; Michael J. Fox Foundation for Parkinson's Research |
nlx_158130 | SCR_003824 | reMYND NV | 2026-07-25 12:05:44 | 1 | |||||||
|
Diamyd Medical Resource Report Resource Website 1+ mentions |
Diamyd Medical (RRID:SCR_003930) | DMYD B | commercial organization | A diabetes company active in the field of pharmaceutical development. The Company develops the diabetes vaccine Diamyd with the active ingredient GAD, which has the potential to become a key piece of the puzzle of a future solution to prevent, treat or cure type 1 diabetes and other forms of diabetes. Diamyd Medical has independently pursued the development of the diabetes vaccine Diamyd to global Phase III trials, leading to one of Sweden''s largest biotech agreements ever. The company has secured an exclusive license for a patent application for the specific combination therapy GAD plus the endogenous substance GABA, which has demonstrated favorable results in preclinical trials. The license also encompasses rights for the therapeutic use of GABA to treat diabetes and other inflammation-related disorders. | pharmaceutical, drug development, drug | is related to: Pharma-Planta Consortium | Type 1 diabetes, Diabetes | nlx_158298 | SCR_003930 | Diamyd Medical AB | 2026-07-25 12:05:46 | 2 | |||||||
|
Heptares Therapeutics Resource Report Resource Website |
Heptares Therapeutics (RRID:SCR_000499) | commercial organization | A drug discovery company focused on small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets. Heptares creates new medicines targeting previously undruggable or challenging GPCRs, a superfamily of receptors linked to many diseases. They are pioneering a structure-based drug design approach to GPCRs, leveraging proprietary technologies for protein stabilization, structure determination, and fragment-based discovery. Their partners include Cubist, MorphoSys, AstraZeneca, MedImmune and Takeda. Their objective is to build a broad pipeline of novel medicines to transform the treatment of serious diseases, including Alzheimer's disease, schizophrenia, diabetes, ADHD and chronic migraine. | g-protein coupled receptor, small molecule, drug, biotechnology, medicine, antibody, drug discovery | is related to: Kinetics for Drug Discovery | Alzheimer's disease, Schizophrenia, Diabetes, Attention deficit-hyperactivity disorder, Chronic migraine | nlx_158498, grid.450873.d, ISNI: 0000 0004 0456 4700 | https://ror.org/051fk5x88 | SCR_000499 | Heptares Therapeutics Limited, Heptares Therapeutics Ltd, Heptares | 2026-07-25 12:04:46 | 0 | |||||||
|
Merck Resource Report Resource Website 10000+ mentions |
Merck (RRID:SCR_001287) | Merck | commercial organization | An American pharmaceutical company aiming to make a difference in the lives of people globally through their medicines, vaccines, biologic therapies and animal health products. | pharmaceutical, merck sharp & dohme corp, merck sharp and dohme corp, merck sharp and dohme, merck sharp & dohme corp., msd, medicine, endocrinology, neuroscience, oncology, respiratory, immunology, vaccine, animal health, veterinary |
uses: Kaggle uses: Tableau Desktop uses: FluoroFinder is affiliated with: European Federation of Pharmaceutical Industries and Associations is related to: eTRIKS is related to: OncoTrack is related to: European Lead Factory is related to: GetReal is related to: Investigator Databank is related to: Kinetics for Drug Discovery is related to: MIP-DILI is related to: ORBITO is related to: PharmaCog is related to: Asian Cancer Research Group is related to: Open PHACTS is related to: Collaboratory of AIDS Researchers for Eradciation (CARE) is parent organization of: MEDINA Foundation is parent organization of: Asian Cancer Research Group is parent organization of: Asia Training Consortium |
Diabetes, Cancer, Cardiovascular disease, Infectious disease | Crossref funder ID: 100004334, grid.417993.1, Wikidata: Q247489, ISNI: 0000 0001 2260 0793, nlx_152409 | https://ror.org/02891sr49 | SCR_001287 | Merck and Co., Merck and Co. Inc., Merck & Co. Inc., Merck & Co. | 2026-07-25 12:05:02 | 10277 | ||||||
|
Foundation for the National Institutes of Health Resource Report Resource Website 1000+ mentions |
Foundation for the National Institutes of Health (RRID:SCR_004493) | FNIH | institution | A public charity whose mission is to support the NIH in its mission to improve health, by forming and facilitating public-private partnerships for biomedical research and training. Its vision is Building Partnerships for Discovery and Innovation to Improve Health. The FNIH draws together the world''s foremost researchers and resources, pressing the frontier to advance critical discoveries. They are recognized as the number-one medical research charity in the countryleveraging support, and convening high level partnerships, for the greatest impact on the most urgent medical challenges we face today. Grants are awarded as part of a public-private partnership with the National Heart, Lung, and Blood Institute (NHLBI) on behalf of The Heart Truth in support of women''s heart health education and research. Funding for the Community Action Program is provided by the FNIH through donations from individuals and corporations including The Heart Truth partners Belk Department Stores, Diet Coke, and Swarovski. Successful biomedical research relies upon the knowledge, training and dedication of those who conduct it. Bringing multiple disciplines to bear on health challenges requires innovation and collaboration on the part of scientists. Foundation for NIH partnerships operate in a variety of ways and formats to recruit, train, empower and retain their next generation of researchers. From lectures and multi-week courses, to scholarships and awards through fellowships and residential training programs, their programs respond to the needs of scientists at every level and stage in their careers. | biomedical research |
is related to: Osteoarthritis Biomarkers Project (OABP) is parent organization of: Biomarkers Consortium is parent organization of: Observational Medical Outcomes Partnership is parent organization of: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is parent organization of: Accelerating Medicines Partnership - Alzheimers is parent organization of: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) is parent organization of: Genetic Association Information Network (GAIN) |
Type 1 diabetes, Type 2 diabetes, Diabetes, Metabolic disease, Alzheimer's disease, Schizophrenia, Prostate cancer, Demantia, Muscular dystrophy, Tuberculosis, HIV, Parkinson's disease, Osteoarthritis, Age-related eye disease, Visceral leishmaniasis, Undiagnosed disease, Cancer, Non-small cell lung cancer, Malaria, Systemic lupus erythematosus, COVID-19, Acute lymphoblastic leukemia | ISNI: 0000 0000 9836 9834, Wikidata: Q16837497, nlx_143768, Crossref funder ID: 100000009, grid.428807.1 | https://ror.org/00k86s890 | SCR_004493 | Foundation for NIH | 2026-07-25 12:05:52 | 1788 | ||||||
|
American Diabetes Association Resource Report Resource Website 1000+ mentions |
American Diabetes Association (RRID:SCR_004526) | ADA | non profit organization | The mission of the American Diabetes Association (ADA) is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. We lead the fight against the deadly consequences of diabetes and fight for those affectedby diabetes. * We fund research to prevent, cure and manage diabetes. * We deliver services to hundreds of communities. * We provide objective and credible information. * We give voice to those denied their rights because of diabetes. | diabetes, diabetes mellitus, type 1 diabetes, type 2 diabetes, gestational diabetes | Type 1 diabetes, Type 2 diabetes, Diabetes | Crossref funder ID: 100000041, ISNI: 0000 0001 1033 6008, Wikidata: Q4743610, nlx_143804, grid.427608.f | https://ror.org/04f6cgz95 | SCR_004526 | 2026-07-25 12:05:52 | 1256 | ||||||||
|
Helmsley Charitable Trust Resource Report Resource Website |
Helmsley Charitable Trust (RRID:SCR_005111) | Helmsley Charitable Trust | funding resource | The Leona M. and Harry B. Helmsley Charitable Trust supports a broad spectrum of healthcare and medical research-based programs. The areas supported include Type 1 Diabetes, Digestive Diseases, Rural Healthcare, Cardiology, and a range of other programs and institutions. | grant, health, medical research, type 1 diabetes, digestive disease, rural healthcare, cardiology | is parent organization of: Helmsley Cellular Research Hub | Type 1 diabetes, Diabetes, Crohn's disease | nlx_144118 | SCR_005111 | Leona M. and Harry B. Helmsley Charitable Trust, Leona M. Harry B. Helmsley Charitable Trust | 2026-07-25 12:05:59 | 0 | |||||||
|
T1D Exchange Resource Report Resource Website 10+ mentions |
T1D Exchange (RRID:SCR_014532) | commercial organization | Provides access to resources T1D researchers need to conduct clinical studies. Data sets from their clinic registry is openly available, as are new study results. They also offer use of T1D Discovery Tool, which allows users to search different fields from registry data, and T1D Exchange Biobank, which offers specimen types such as serum, plasma, white blood cells, DNA, and RNA. | portal, dataset, type 1 diabetes, t1d, clinical, study, registry, data |
is listed by: NIDDK Information Network (dkNET) is related to: Type 1 Diabetes Knowledge Portal is parent organization of: T1D Exchange Biobank |
Type 1 diabetes, Diabetes | grid.461811.b | https://ror.org/016jvas21 | SCR_014532 | T1D Exchange Inc. | 2026-07-25 12:08:04 | 12 | |||||||
|
Accelerating Medicines Partnership Resource Report Resource Website 1+ mentions |
Accelerating Medicines Partnership (RRID:SCR_014927) | AMP | group | Partnership between the National Institutes of Health (NIH), the U.S. Food and Drug Administration (FDA), and multiple biopharmaceutical companies and non-profit organizations whose goal is to increase the number of new diagnostics and therapies for patients and reduce the time and cost of developing them. The group explores three major areas of disease: diabetes, Alzheimer's disease, and rheumatoid arthritis and lupus. | group, partnership, nih, fda, medicine, diabetes, alzheimers, alzheimer's, rheumatoid arthritis, lupus |
has parent organization: National Institutes of Health is parent organization of: Accelerating Medicines Partnership Autoimmune Diseases of Rheumatoid Arthritis and Lupus is parent organization of: Accelerating Medicines Partnership - Alzheimers is parent organization of: Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal (AMP-T2D) |
diabetes, Alzheimer's disease, rheumatoid arthritis, lupus | SCR_014927 | Accelerating Medicines Partnership (AMP) | 2026-07-25 12:08:09 | 3 | ||||||||
|
Attie Lab Diabetes Database Resource Report Resource Website 1+ mentions |
Attie Lab Diabetes Database (RRID:SCR_016639) | database, data or information resource | Interactive database of gene expression and diabetes related clinical phenotypes. Allows to search gene expression in tissues as a function of obesity, strain, and age, in a mouse. | interactive, database, gene, expression, diabetes, related, clinical, phenotype, mouse |
is listed by: OMICtools has parent organization: University of Wisconsin-Madison; Wisconsin; USA |
diabetes | Free, Freely available | SCR_016639 | 2026-07-25 12:12:12 | 3 | |||||||||
|
Diabetes Prevention Type 1 Resource Report Resource Website |
Diabetes Prevention Type 1 (RRID:SCR_001467) | DPT-1 | biomaterial supply resource, material resource | Data set and biosepecimens of a multi-center clinical trial to determine if treatment with beta-cell antigens can delay the onset of Type 1 Diabetes Mellitus (Type 1 DM) in non-diabetic relatives of persons with Type 1 DM. Insulin is a well characterized antigen specifically produced by beta-cells, and it was used for this purpose in the initial DPT-1 studies. The protocol for high risk subjects uses daily subcutaneous insulin injections and an annual course of intravenous insulin treatment, while the protocol for intermediate risk subjects uses daily doses of insulin administered orally. Neither injected nor oral insulin at the doses used were observed to delay or prevent diabetes, although further studies are needed to test whether oral insulin can delay diabetes in people in the intermediate risk group with high titers of insulin autoantibodies. | beta cell antigen, insulin, prevention, onset, subcutaneous injection, oral, intravenous, treatment, randomized, controlled trial, drug therapy, delay |
is listed by: One Mind Biospecimen Bank Listing is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: Diabetes Research Centers |
Type 1 diabetes, Diabetes | NIDDK UC4 DK097835 | Free, Freely Available | nlx_152696 | https://www.niddkrepository.org/niddk/jsp/public/dataset.jsp#DPT-1 | SCR_001467 | Diabetes Prevention Trial--Type 1 (DPT-1) dataset, DPT-1 (The Diabetes Prevention Type 1) | 2026-07-25 12:12:22 | 0 | ||||
|
Resource for Genetic Epidemiology Research on Adult Health and Aging Resource Report Resource Website 1+ mentions |
Resource for Genetic Epidemiology Research on Adult Health and Aging (RRID:SCR_010472) | GERA | database, data or information resource | Human genetics data from an immense (78,000) and ethnically diverse population available for secondary analysis to qualified researchers through the database of Genotypes and Phenotypes (dbGaP). It offers the opportunity to identify potential genetic risks and influences on a broad range of health conditions, particularly those related to aging. The GERA cohort is part of the Research Program on Genes, Environment, and Health (RPGEH), which includes more than 430,000 adult members of the Kaiser Permanente Northern California system. Data from this larger cohort include electronic medical records, behavioral and demographic information from surveys, and saliva samples from 200,000 participants obtained with informed consent for genomic and other analyses. The RPGEH database was made possible largely through early support from the Robert Wood Johnson Foundation to accelerate such health research. The genetic information in the GERA cohort translates into more than 55 billion bits of genetic data. Using newly developed techniques, the researchers conducted genome-wide scans to rapidly identify single nucleotide polymorphisms (SNPs) in the genomes of the people in the GERA cohort. These data will form the basis of genome-wide association studies (GWAS) that can look at hundreds of thousands to millions of SNPs at the same time. The RPGEH then combined the genetic data with information derived from Kaiser Permanente''s comprehensive longitudinal electronic medical records, as well as extensive survey data on participants'' health habits and backgrounds, providing researchers with an unparalleled research resource. As information is added to the Kaiser-UCSF database, the dbGaP database will also be updated. | genotype, phenotype, genome-wide association study, saliva, dna, male, female, health condition, electronic medical record, single nucleotide polymorphism, adult human, late adult human, gene, genome |
has parent organization: NCBI database of Genotypes and Phenotypes (dbGap) has parent organization: University of California at San Francisco; California; USA |
Aging, Cardiovascular disease, Osteoarthritis, Depressive Disorder, Insomnia, Eye disease, Cancer, Diabetes | NIMH ; NIH Office of the Director ; NIA AG036607 |
Application required, Non-commercial, Data Use Certification Agreement | nlx_157735 | SCR_010472 | Genetic Epidemiology Research on Aging | 2026-07-25 12:11:58 | 9 | |||||
|
HIRN Human Pancreas Analysis Program Resource Report Resource Website 100+ mentions |
HIRN Human Pancreas Analysis Program (RRID:SCR_016202) | HIRN-HPAP, HPAP | database, data or information resource | Program is performing deep phenotyping of human endocrine pancreas and its interaction with immune system to better understand cellular and molecular events that precede and lead to beta cell loss in Type-1 Diabetes (T1D) and islet dysfunction in Type-2 Diabetes (T2D). | pancreas, endocrinology, immunology, molecular, biology, human, t1d, beta, cell |
has parent organization: HIRN Human Pancreas Analysis Consortium is organization facet of: Human Islet Research Network (HIRN) |
Type 1 diabetes, Diabetes | NIDDK ; NIDDK U01 DK104162; NIDDK UC4 DK112217; NIDDK UC4 DK112232 |
PMID:31127054 | https://hirnetwork.org/consortium/hpap | SCR_016202 | Human Pancreas Analysis Program (HIRN-HPAP), PANC-DB | 2026-07-25 12:12:12 | 120 | |||||
|
Ohio U Diabetes Endocrine Biorepository Resource Report Resource Website |
Ohio U Diabetes Endocrine Biorepository (RRID:SCR_013435) | Ohio University Diabetes/Endocrine Diseases Biorepository | biomaterial supply resource, material resource | Plasma and cell fractions obtained from patients with Diabetes and endocrine diseases and their first degree relatives who agreed to participate in the development of the biorepository. Plasma is aliquoted into multiple specimen containers and stored at -80C. Cell fractions are subjected to DNA and RNA fractionation, aliquoted into multiple specimen containers, and frozen at -70 to -80 degrees centigrade. Anyone who would like to obtain samples from the Biorepository must provide evidence that they have adequate training in the use of bloodborne pathogens, as outlined by OSHA. The investigator must agree to indemnify and hold harmless the Ohio University Diabetes/Endocrine Diseases Biorepository, the Appalachian Rural health Institute, and the Ohio University College of Osteopathic Medicine from any claims, liability, costs, and damages. | blood, plasma, cell fraction, dna, rna, frozen, diabetes, endocrine disease |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Ohio University; Ohio; USA |
Diabetes, Endocrine disease | Available to qualified researchers | nlx_66534 | SCR_013435 | Ohio University Diabetes / Endocrine Diseases Biorepository, Diabetes / Endocrine Diseases Biorepository | 2026-07-25 12:12:54 | 0 | ||||||
|
Type 1 Diabetes - Rapid Access to Intervention Development Resource Report Resource Website |
Type 1 Diabetes - Rapid Access to Intervention Development (RRID:SCR_000203) | T1D-RAID | resource, service resource | NOTE: The T1D-RAID program is not currently accepting applications. Cooperative program that makes available, on a competitive basis, NCI resources for the pre-clinical development of drugs, natural products, and biologics to facilitate translation to the clinic of novel, scientifically meritorious therapeutic interventions for type 1 diabetes and its complications. A partial listing of those services includes: high-throughput screening, studies in animal models, formulation, pharmacology and toxicology studies, and bulk substances acquisition. Requests to T1D-RAID are brief (20 pages or less), and should clearly outline the resources required to ready the proposed therapeutic agent for clinical trials. T1D-RAID should enable entry into the clinic of promising molecules that are not otherwise likely to receive an adequate and timely clinical test. T1D-RAID is designed to accomplish the tasks that are rate-limiting in bringing discoveries from the laboratory to the clinic. Once a project has been approved, NIDDKstaff interact directly with the Principal Investigator (PI). NCI contractors perform the T1D-RAID-approved tasks under the direction of NIDDKand NCI staff. The required tasks will vary from project to project. In some cases T1D-RAID will support only one or two key missing steps necessary to bring a compound to the clinic; in other cases it may be necessary to supply the entire portfolio of development requirements needed to file an IND. Examples of tasks that can be supported by T1D-RAID include, but are not limited to: * Definition or optimization of dose and schedule for in vivo activity * Development of pharmacology assays * Conduct of pharmacology studies with a pre-determined assay * Acquisition of bulk substance (GMP and non-GMP) * Scale-up production from lab-scale to clinical-trials lot scale * Development of suitable formulations * Development of analytical methods for bulk substances * Production of dosage forms * Stability assurance of dosage forms * Range-finding initial toxicology * IND-directed toxicology, with correlative pharmacology and histopathology * Planning of clinical trials * Regulatory affairs, so that FDA requirements are likely to be satisfied by participating investigators seeking to test new molecular entities in the clinic * IND filing advice The output of T1D-RAID activities will be both products and information that will be made fully available to the originating investigator for support of an IND application and clinical trials. T1D-RAID does not sponsor clinical trials. | therapeutic, drug, drug development, pharmacogenomics |
is listed by: NIDDK Information Network (dkNET) is related to: Type 1 Diabetes Preclinical Testing Program has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Diabetes | NCI ; NIDDK |
nlx_152742 | SCR_000203 | Type 1 Diabetes - Rapid Access to Intervention Development (T1D-RAID) | 2026-07-25 12:13:17 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the PRECISE-TBI Resources search. From here you can search through a compilation of resources used by PRECISE-TBI and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that PRECISE-TBI has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on PRECISE-TBI then you can log in from here to get additional features in PRECISE-TBI such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into PRECISE-TBI you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
